Research and Development

Showing 15 posts of 9599 posts found.

Risking it all after the pandemic: How companies can pick up the slack post-COVID-19

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …

Breakthrough status given to Renew Bioscience’s Alzheimer’s treatment

November 3, 2021 Research and Development

Renew Bioscience announced it has received Breakthrough Device Designation status from the FDA for the Cerezen® Device, a novel treatment …

Covid jabs more effective than virus at preventing infection

November 3, 2021 Research and Development

A US study has revealed that the immunity received from COVID-19 vaccines is much stronger than that stimulated by infection …
beverley-carr-enhanced

Beverley Carr appointed Chief Business Officer for Amphista Therapeutics

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amphista, appointments

Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …

Mogrify appoint Tom Graney Non-Executive Director, Audit Chair and Capital Markets Advisor

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, mogrify

Mogrify Limited have announced the appointment of Tom Graney, CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He …

Plan C COVID strategy being discussed by government

October 27, 2021 Research and Development

An advisor to the Department of Health told MPs a ‘Plan C’ has been mentioned in Government discussions, should the …

Quell Therapeutics receives CTA approval to begin first clinical trial with a multi-modular engineered treg cell company

October 27, 2021 Research and Development

The MHRA has approved Quell Therapeutics’ first clinical trial for its lead cell therapy candidate QEL-001. This approval paves the …

Study finds link between COVID-19 infection and neurological complications

October 27, 2021 Research and Development

A study conducted by Nature Medicine has revealed an increased risk of Guillain-Barre Syndrome (GBS) and Bell’s palsy following a …

FDA and EMA approve Novartis’ treatment for follicular lymphoma patients

October 27, 2021 Research and Development

The FDA and EMA have accepted Novartis’ Supplemental Biologics License Application (sBLA) and Type II Variation for KymriahⓇ in patients …

IXICO partner with Microsoft to enhance AI platform

October 20, 2021 Research and Development

IXICO, an AI data analytics company delivering insights into neuroscience, have announced a collaboration with Microsoft to develop its AI …

Synairgen COVID-19 treatment moves to Phase III trials

October 20, 2021 Research and Development

Synairgen PLC have said that its anti-viral treatment for severe lung infections is advancing to the final stage of clinical …

Pharma Innovation Award given to Stevanato Group for AI-ready vision Robot Unit

October 20, 2021 Research and Development

Stevanato Group, a global provider of processes and services for the Pharmaceutical and Healthcare industry, has been announced as a …
mufid-majnun-oi20ehignd4-unsplash

UK COVID deaths highest since March – Doctors call for urgent return of restrictions

October 20, 2021 Research and Development

Medical professionals in the NHS have urgently pleaded the UK government to reimpose COVID restrictions as UK COVID deaths reach …

England care staff shortage puts thousands at risk

October 20, 2021 Research and Development

Managers of community care services for over 15,000 people in England say that staff shortages have led to them turning …

Verona Pharma to present Phase II data with pMDI for COPD patients

October 13, 2021 Research and Development

Clinical-stage biopharmaceutical company, Verona Pharma plc (Verona), is due to present Phase II data demonstrating the positive effect of a …
The Gateway to Local Adoption Series

Latest content